Diurnal, weekly, and long-time variation in serum concentrations of YKL-40 in healthy subjects

被引:64
作者
Johansen, Julia S. [1 ]
Lottenburger, Tine [6 ]
Nielsen, Hans Jorgen [2 ]
Jensen, Jens Erik B. [3 ]
Svendsen, Mads N. [2 ]
Kollerup, Gine [4 ]
Christensen, Ib J. [2 ,5 ]
机构
[1] Univ Copenhagen, Herlev Hosp, Dept Rheumatol, DK-1168 Copenhagen, Denmark
[2] Univ Copenhagen, Hvidovre Hosp, Dept Surg Gastroenterol, DK-1168 Copenhagen, Denmark
[3] Univ Copenhagen, Hvidovre Hosp, Dept Endocrinol, DK-1168 Copenhagen, Denmark
[4] Univ Copenhagen, Bispebjerg Hosp, Dept Rheumatol, DK-1168 Copenhagen, Denmark
[5] Rigshosp, Finsen Lab, Copenhagen Bioctr, DK-2100 Copenhagen, Denmark
[6] Univ So Denmark, Grasten Rheumatism Hosp, Grasten, Denmark
关键词
D O I
10.1158/1055-9965.EPI-07-2766
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Serum YKL-40 is a potential biomarker of prognosis in cancer patients, but assessment of serum YKL-40 requires knowledge of its normal variation. In this study, we evaluated diurnal, weekly, and long-term variation in serum YKL-40 in healthy subjects using a commercial ELISA. The intra-assay coefficient of variation was <= 5.0% and interassay <= 10.2%. Systematic changes in diurnal measurements of serum YKL-40 could not be shown. Physical exercise for 20 min had no effect on serum YKL-40. The within-subject coefficient of variation, including variation over time and interassay, was 28.8% and 30.2% over a period of 2 and 3 years, and the intraclass correlation coefficients were 72.4% and 72.2%, indicating reasonable reliability of serum YKL-40 measurements. The 95% confidence limits for the difference between two measurements (same subject), including interassay variation, were a 52% reduction and a 109% increase in serum YKL-40. These studies show that relatively small variation is found in serum YKL-40 in healthy subjects. However, a single measurement of serum YKL-40 from an individual may not have a propnostic value, and serum YKL-40 alone cannot be a good biomarker for cancer because serum YKL-40 can be elevated in patients with other diseases characterized by inflammation and tissue remodeling.
引用
收藏
页码:2603 / 2608
页数:6
相关论文
共 35 条
[1]
High serum concentration of YKL-40 is associated with short survival in patients with acute myeloid leukemia [J].
Bergmann, OJ ;
Johansen, JS ;
Klausen, TW ;
Mylin, AK ;
Kristensen, JS ;
Kjeldsen, E ;
Johnsen, HE .
CLINICAL CANCER RESEARCH, 2005, 11 (24) :8644-8652
[2]
The mammalian chitinase-like lectin, YKL-40, binds specifically to type I collagen and modulates the rate of type I collagen fibril formation [J].
Bigg, Heather F. ;
Wait, Robin ;
Rowan, Andrew D. ;
Cawston, Tim E. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (30) :21082-21095
[3]
Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma [J].
Brasso, K ;
Christensen, IJ ;
Johansen, JS ;
Teisner, B ;
Garnero, P ;
Price, PA ;
Iversen, P .
PROSTATE, 2006, 66 (05) :503-513
[4]
A chitinase-like protein in the lung and circulation of patients with severe asthma [J].
Chupp, Geoffrey L. ;
Lee, Chun Geun ;
Jarjour, Nizar ;
Shim, Yun Michael ;
Holm, Carole T. ;
He, Susan ;
Dziura, James D. ;
Reed, Jennifer ;
Coyle, Anthony J. ;
Kiener, Peter ;
Cullen, Mark ;
Grandsaigne, Martine ;
Dombret, Marie-Christine ;
Aubier, Michel ;
Pretolani, Marina ;
Elias, Jack A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (20) :2016-2027
[5]
Serum YKL-40 and colorectal cancer [J].
Cintin, C ;
Johansen, JS ;
Christensen, IJ ;
Price, PA ;
Sorensen, S ;
Nielsen, HJ .
BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) :1494-1499
[6]
High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival [J].
Cintin, C ;
Johansen, JS ;
Christensen, IJ ;
Price, PA ;
Sorensen, S ;
Nielsen, HJ .
CANCER, 2002, 95 (02) :267-274
[7]
Clarke R, 1999, AM J EPIDEMIOL, V150, P341
[8]
Coskun U, 2007, NEOPLASMA, V54, P348
[9]
Preoperative serum YK-L-40 is a marker for detection and prognosis of endometrial cancer [J].
Diefenbach, Catherine S. M. ;
Shah, Zharria ;
Iasonos, Alexia ;
Barakat, Richard R. ;
Levine, Douglas A. ;
Aghajanian, Carol ;
Sabbatini, Paul ;
Hensley, Martee L. ;
Konner, Jason ;
Tew, William ;
Spriggs, David ;
Fleisher, Martin ;
Thaler, Howard ;
Dupont, Jakob .
GYNECOLOGIC ONCOLOGY, 2007, 104 (02) :435-442
[10]
Early detection and prognosis of ovarian cancer using serum YKL-40 [J].
Dupont, J ;
Tanwar, MK ;
Thaler, HT ;
Fleisher, M ;
Kauff, N ;
Hensley, ML ;
Sabbatini, P ;
Anderson, S ;
Aghajanian, C ;
Holland, EC ;
Spriggs, DR .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) :3330-3339